Fabrication and In Vitro Characterization of a Meloxicam Film-Forming Topical Spray

Background: Film-forming topical sprays are polymer-based systems that form a thin film after application and may provide localized drug delivery while avoiding some limitations of conventional topical dosage forms. Meloxicam is a non-steroidal anti-inflammatory drug with potential utility in topical delivery. Objective: To formulate Meloxicam-containing film-forming topical spray systems and evaluate their selected physicochemical properties and in-vitro drug release. Methods: Six formulations (F1–F6) were described in the thesis. Preformulation assessment included organoleptic properties, melting point, solubility, UV spectrophotometric analysis, calibration-curve development and FTIR compatibility assessment. Prepared systems were evaluated for appearance, weight uniformity, thickness, folding endurance, drug content and in-vitro release using a Franz diffusion cell with phosphate buffer (pH 6.8) at 37 ± 0.2 °C. Results: Meloxicam showed a reported absorption maximum of 365 nm and an experimental melting-point range of 251–254 °C. The calibration curve was reported as linear over 0–25 µg/mL (r = 0.999). Film weights ranged from 0.123 ± 0.0085 to 0.139 ± 0.0063 g, and thickness ranged from 0.54 ± 0.05 to 0.62 ± 0.05 mm. Drug content ranged from 92.31 ± 0.345% to 97.40 ± 0.425%. F6 was identified by the thesis as the optimized formulation. The reported eight-hour release values ranged from 72.86% to 92.61%, with F1 showing the highest and F6 the lowest release. Conclusion: Meloxicam-containing film-forming systems were prepared and evaluated, and F6 was designated as the optimized batch in the source thesis. Confirmation of formulation composition and the release dataset is required before drawing definitive comparative conclusions.

Authors

Institutions

Publication Details

Journal
TMP Universal Journal of Advances in Pharmaceutical sciences
Published
2026-11-19
DOI
https://doi.org/10.69557/65xmbn64
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fabrication and In Vitro Characterization of a Meloxicam Film-Forming Topical Spray

Jeevan Patel
TMP Universal Journal of Advances in Pharmaceutical sciences
Advancements in Transdermal Drug Delivery
article

Fabrication and In Vitro Characterization of a Meloxicam Film-Forming Topical Spray

Jeevan Patel
article en

Abstract

Background: Film-forming topical sprays are polymer-based systems that form a thin film after application and may provide localized drug delivery while avoiding some limitations of conventional topical dosage forms. Meloxicam is a non-steroidal anti-inflammatory drug with potential utility in topical delivery. Objective: To formulate Meloxicam-containing film-forming topical spray systems and evaluate their selected physicochemical properties and in-vitro drug release. Methods: Six formulations (F1–F6) were described in the thesis. Preformulation assessment included organoleptic properties, melting point, solubility, UV spectrophotometric analysis, calibration-curve development and FTIR compatibility assessment. Prepared systems were evaluated for appearance, weight uniformity, thickness, folding endurance, drug content and in-vitro release using a Franz diffusion cell with phosphate buffer (pH 6.8) at 37 ± 0.2 °C. Results: Meloxicam showed a reported absorption maximum of 365 nm and an experimental melting-point range of 251–254 °C. The calibration curve was reported as linear over 0–25 µg/mL (r = 0.999). Film weights ranged from 0.123 ± 0.0085 to 0.139 ± 0.0063 g, and thickness ranged from 0.54 ± 0.05 to 0.62 ± 0.05 mm. Drug content ranged from 92.31 ± 0.345% to 97.40 ± 0.425%. F6 was identified by the thesis as the optimized formulation. The reported eight-hour release values ranged from 72.86% to 92.61%, with F1 showing the highest and F6 the lowest release. Conclusion: Meloxicam-containing film-forming systems were prepared and evaluated, and F6 was designated as the optimized batch in the source thesis. Confirmation of formulation composition and the release dataset is required before drawing definitive comparative conclusions.

TMP Universal Journal of Advances in Pharmaceutical sciencesVol. 2(4)
Oriental University (RU)
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon